The deal would be the first move by a Romanian private medical sector company abroad.
“Hungary is a less developed market than Romania and we are in advanced talks with a medical company there. We may have a deal as soon as this quarter. The market demands it. We don’t intend to invest more than EUR4 million to EUR5 million abroad at first,” Mihai Marcu told ZF.
MedLife, which is included in the main index of the Bucharest Stock Exchange, BET, has a capitalization of 607 million lei (EUR129 million). It has gained 2.2% on the stock market since the beginning of the year, while the BET dropped 2.5%. MedLife group posted RON579 million revenue for the first nine months of 2018, according to the latest officially available data, up 26% on the same time in 2017, as well as 33% higher profit, RON12.7 million.(EUR1=RON4.7081)
(English version by Loredana Fratila-Cristescu)